Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer

CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer

US Patent 11407721 · Granted Aug 9, 2022

Estimated economic value: $237,532,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Thiadiazolyl derivatives2025
CDK inhibitors and uses thereof2025
Substituted pyrido [4,3-d]pyrimidines as KRAS modulators2025
Broad spectrum antiviral compositions and methods2025
CD73 inhibitors2025
ERK inhibitors and uses thereof2025
Amorphous and crystalline forms of IDO inhibitors2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds2025
ASK1 inhibiting agents2025
Thiazole compounds and methods of use thereof2025
Compounds, compositions and methods2025
Fluoroalkyl-oxadiazoles and uses thereof2025